Trial Profile
Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2021
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FAMILY
- Sponsors Genesis Pharma
- 02 Feb 2021 Results published in the Advances in Therapy
- 13 Feb 2019 Status changed from active, no longer recruiting to completed.
- 31 Jul 2018 Planned End Date changed from 7 Mar 2018 to 30 Nov 2018.